top of page

Prof Christopher Kipps

PhD, MBBS

Consultant Neurologist; Honorary Professor of Clinical Neurology and Dementia; Clinical Director of R&D; Director of Southampton Emerging Therapies and Technologies (SETT) Centre

blank-profile-picture-973460_640.png
google scolar.png

Professor Kipps is a Consultant Neurologist at Wessex Neurological Centre (Southampton) and Professor at University of Southampton. 


He has an active research programme in dementia and long-term neurological conditions, leading in a range of interventional and observational trials. He has research interests in digital tools to support care and implementation of secure data environments (SDE) to address research questions in health and social care.


He is Clinical Director for R&D at UHS and the Southampton Emerging Therapies and Technologies (SETT) centre and has leadership roles in Wessex ARC, CRN and the Wessex SDE programme.


Landmark publications:


Fearn S, … Kipps C, The Causes and Impact of Crisis for People with Parkinson's Disease: A Patient and Carer Perspective (2021) J Parkinsons Dis. doi: 10.3233/JPD-212641


Prosser AMJ, Spreadbury JH, Tosci-Bolt L, Kipps CM, Imaging Care Requirements: Use of Functional HMPAO- SPECT Scanning to Predict Caregiver Burden (2018) Dementia Geriatric Cogn Dis Extra 26 (1):180-189


Walker T, Ghosh B, Kipps C; Assessing Decline: Visualising Progression in Huntington’s Disease using a Clinical Dashboard with Enroll-HD Data (2017); J Huntington’s Dis. 6(2):139-147


Rascovsky K, …,Kipps CM, …Miller BL. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain, 2011. 134(9): 2456-77.


Kipps CM, Nestor PJ, Dawson CE, Mitchell J, Hodges JR. Measuring progression in frontotemporal dementia: implications for therapeutic interventions. Neurology 2008 May 27;70:2046-2052.


Major grants:

  • 2020 Kipps. Health Foundation, Neuro Online – Use, uptake, utility and effectiveness. £0.07M

  • 2021 Chance, Kipps. I4i NIHR. Cortical Disarray Measurement in Dementia. £1.40M

  • 2021 Kipps. Health Foundation. Health Economic Evaluation of MyMR. £0.05M

  • 2021 Chan, Kipps. NIHR. Cognitive Impairment in Long Covid: phenotyping and rehabilitation (CICERO). £1.18M

  • 2021 Kipps. Wessex ARC. Strategies to improve uptake, use and utility of digital care in long-term neurological conditions. £0.18M

  • 2021 Kipps. NHSX. Wessex Locality TRE for Real World Evaluation. £0.50M

  • 2022 Kipps. NHSE. Subnational TRE Wave 2. £0.30M


bottom of page